Cargando…
Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study
Background: Recent explorative studies suggest that propranolol reduces retinopathy of prematurity (ROP) progression, but the short-term effects of propranolol treatment at 1 year of corrected age have not been extensively evaluated. Methods: A multi-center retrospective observational cohort study w...
Autores principales: | Filippi, Luca, Cavallaro, Giacomo, Perciasepe, Lavinia, Sandini, Elena, Araimo, Gabriella, Regiroli, Giulia, Raffaeli, Genny, Bagnoli, Paola, Dal Monte, Massimo, Calvani, Maura, Fortunato, Pina, Osnaghi, Silvia, De Masi, Salvatore, Mosca, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863805/ https://www.ncbi.nlm.nih.gov/pubmed/31799228 http://dx.doi.org/10.3389/fped.2019.00479 |
Ejemplares similares
-
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491
por: Filippi, Luca, et al.
Publicado: (2010) -
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
por: Filippi, Luca, et al.
Publicado: (2019) -
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
por: Filippi, Luca, et al.
Publicado: (2017) -
Refractive Development in the “ROP Rat”
por: Chui, Toco Y. P., et al.
Publicado: (2012) -
Propranolol eye drops in patients with corneal neovascularization
por: Filippi, Luca, et al.
Publicado: (2018)